EL CID Investments Ltd

EL CID Investments Ltd: Trading Window closed from Friday, September 25, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026

Financial results

• Unaudited standalone and consolidated Q1 2026 results approved (quarter ended June 30, 2026).
• Limited review report approved along with the results.

Risk Management Committee constituted

• Risk Management Committee constituted with four members, effective Aug 14, 2026.

CSR Committee reconstituted

• CSR Committee reconstituted; chair Ragini Vakil, members Amrita Vakil and Essaji Vahanvati; effective Aug 14, 2026.

Governance/compliance notes

• Formation disclosed; no other material regulatory issues noted.

Meeting Details

• Board meeting scheduled for Aug 13, 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2026.

Other Notes

• No trading window closure details disclosed; no other material notes.

Appointment of Amrita Vakil as Director

• Appointment of Ms. Amrita Vakil as Director, liable to retire by rotation.
• Effective date: 31 July 2026; term not fixed, retirement by rotation at AGM.
• Reason: Approved by shareholders at 45th AGM.
• Profile: BSc in HR and Economics from Michigan State; experience at Asian Paints, Frost Sullivan, Elcid.

Re-appointment of Kartikeya Kaji as Independent Director

• Re-appointment of Mr. Kartikeya Kaji as Independent Director.
• Term: 1 Apr 2027 to 31 Mar 2032 (second five-year term).
• Reason: Shareholders approved at 45th AGM.
• Profile: Ex-MD at Kedaara Capital; partner at Vitruvian; Wharton MBA; Dartmouth BA.
• Relationships: Not related to any director.
• Debarment: Not debarred by SEBI or other authorities.

AGM outcomes and governance actions

• AGM held on 31 July 2026 via VC/OAVM; four resolutions transacted.
• Adoption of standalone and consolidated accounts for year ended 31 March 2026 approved.
• Final dividend of ₹25 per equity share recommended, subject to shareholders' approval; total ~₹50 lakh.
• Re-appointment of Amrita Vakil as Director (retiring by rotation) proposed for re-appointment.
• Re-appointment of Kartikeya Kaji as Independent Director for second term, 2027–2032.
• All four resolutions passed with requisite majority via remote e-voting and AGM.
• No bonus issue or equity split contemplated.

Process status

• Dematerialisation requests processed; confirmations sent to depositories for quarter ended 30 June 2026.
• Securities dematerialised have been listed on the stock exchanges where existing securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled after verification; depository's name substituted as registered owner within timelines.

Financial highlights

• Standalone total income ₹9,482.70 Lakhs; down 32.6% YoY.
• Consolidated total income ₹13,538.00 Lakhs; down 36.6% YoY.
• Standalone PAT ₹7,622.80 Lakhs; down 24.5%.
• Consolidated PAT ₹10,852.04 Lakhs; down 29.0%.
• Standalone EPS ₹3,811.40; Consolidated EPS ₹5,426.02.
• Standalone net profit margin 80.38%; Consolidated 80.16%.
• Standalone current ratio 4.14x; Consolidated 3.97x.
• Debt-free balance sheet; zero borrowings; strong liquidity.

Dividends & capital returns

• Final dividend ₹25 per equity share for FY2025-26.
• Total dividend ₹50.00 Lakhs; record date 24 Jul 2026.
• Dividend payable after AGM, subject to shareholder approval.
• 45th AGM on 31 Jul 2026; VC/OAVM mode.

Governance & board changes

• Amrita Vakil appointed Whole-Time Director on 24 May 2025.
• Margarette Shwetha Thomas appointed Independent Director on 24 May 2025.
• Ragini Vakil appointed Director on 24 May 2025.
• Essaji Vahanvati reappointed Independent Director on 2 Nov 2025.
• Kartikeya Kaji to be reappointed Independent Director (2027–2032).
• Board meetings: seven in FY25-26; six directors; three independents.
• Committees: Audit, NRC, SRC, CSR.

Subsidiaries & regulatory changes

• Two material subsidiaries: Murahar Investments & Trading Co. Ltd; Suptaswar Investments & Trading Co. Ltd; 100% owned.
• RBI COR Type-1 NBFC-ND for both subsidiaries; COR dated 15 Sep 2025.
• MOA amended; CINs updated: Elcid L64990MH1981PLC025770; Murahar U64990MH1979PLC021880; Suptaswar U64990MH1979PLC021876.
• Consolidated statements include subsidiary notes; available on company website.

CSR policy & projects

• CSR policy approved; CSR Committee oversees initiatives; policy on website.
• CSR 2025-26 projects: Cancer treatment in Maharashtra; Palanpur education scholarships; Palanpur scholarships.
• Average net profit ₹24,41,80,662; CSR obligation ₹48,83,613.
• CSR spend ₹50,00,000; excess ₹1,16,387 carried forward.

Audit & internal controls

• Standalone Ind AS: Unmodified opinion from VK Beswal & Associates.
• Internal controls deemed adequate; no material weaknesses disclosed.
• Secretarial Audit: Annexure 4; no observations identified.
• Consolidated: Unmodified opinion; no material misstatements noted.

Risks & outlook

• Positive long-term outlook driven by India's growth, digital adoption and infrastructure.
• Risks: geopolitical tensions, inflation, NBFC regulatory changes, portfolio concentration.
• Outlook: RBI policy easing, strong SIP/institutional flows, FPIs into government securities.
• Portfolio to deliver earnings as the domestic cycle strengthens; maintain debt-free stance.

AGM & investor communications

• Annual General Meeting through VC/OAVM; deemed venue at registered office.
• Record date for dividend: 24 Jul 2026.
• E-voting window: 27-30 Jul 2026; remote via CDSL; details on company site.